Abstract:Cardiovascular disease stands as the leading cause of death globally, claiming approximately 19 million lives in 2020. On the contrary, the development of cardiovascular drugs is experiencing a decline, largely due to the bottleneck in understanding the pathophysiology of various heart diseases and assessing the effects of drugs on healthy human hearts. The development of induced pluripotent stem cell (iPSC) technology and the availability of cardiac cell types in vitro, has resulted in a surge in efforts to fabricate human cardiac models for disease modelling and drug discovery applications. Although numerous attempts evidence successful fabrication of 3 dimensional (3D) engineered heart tissues, the innate immune cell population of the myocardium ;particularly cardiac macrophages, was until recently, overlooked. With increasing appreciation of the interactions between cardiomyocytes and macrophages in the myocardium, in this work, isogenic populations of cardiac resident-like macrophages and cardiomyocytes were generated using iPSCs, to understand the interactions between the two cell types in both 2D and 3D settings, and subjected to electric stimulation. After characterizing iPSC-derived macrophages (iMacs) and iPSC-derived cardiomyocytes (iCMs) in depth, the conditioning of iMacs to align to a cardiac resident macrophage-like phenotype in the presence of iCMs in 2D culture was explored. In coculture with iCMs, iMacs upregulated known genes expressed by cardiac resident macrophages. Additionally, in co-culture with iMacs, iCMs displayed an elongated morphology, improved calcium function and an increase in known maturation genes such as the ratio between MYH7 and MYH6 as well as SERCA2. In a 2D setting, iMacs showed the ability to electrically couple with iCMs and facilitate synchronous beating in iCM cultures. The 2D characterisation was translated into an engineered cardiac tissue model, wherein, improvement in tissue characteristics in the presence of iMacs was demonstrated in terms of increased cell alignment, enhanced cardiomyocyte elongation, physiologically relevant beat rates and improved tissue compaction. Taken together, these findings may open new avenues to use iMacs in engineered cardiac tissue models, not only as an innate immune cell source, but also as a support cell type to improve cardiomyocyte function and maturation.

A microscale biomimetic platform for generation and electro-mechanical stimulation of 3D cardiac microtissues

Enhancing all-in-one bioreactors by combining interstitial perfusion, electrical stimulation, on-line monitoring and testing within a single chamber for cardiac constructs

Bioreactor for modulation of cardiac microtissue phenotype by combined static stretch and electrical stimulation.

Biomimetic Perfusion and Electrical Stimulation Applied in Concert Improved the Assembly of Engineered Cardiac Tissue.

Cardiac Meets Skeletal: What’s New in Microfluidic Models for Muscle Tissue Engineering

A Platform for Generation of Chamber-Specific Cardiac Tissues and Disease Modeling

Continuous Contractile Force and Electrical Signal Recordings of 3D Cardiac Tissue Utilizing Conductive Hydrogel Pillars on a Chip

Biomimetic Cardiac Microsystems for Pathophysiological Studies and Drug Screens

Multifunctional 3D Electrode Platform for Real-Time in Situ Monitoring and Stimulation of Cardiac Tissues

Flexible 3D printed microwires and 3D microelectrodes for heart-on-a-chip engineering

Micro‐Engineered Heart Tissues on‐Chip with Heterotypic Cell Composition Display Self‐Organization and Improved Cardiac Function

Design and fabrication of an integrated heart-on-a-chip platform for construction of cardiac tissue from human iPSC-derived cardiomyocytes and in situ evaluation of physiological function

Microfabricated perfusable cardiac biowire: a platform that mimics native cardiac bundle

Channelled Scaffolds for Engineering Myocardium with Mechanical Stimulation

Generation and maturation of human iPSC-derived 3D organotypic cardiac microtissues in long-term culture

A miniaturized culture platform for control of the metabolic environment

Generation of bioartificial heart tissue by combining a three-dimensional gel-based cardiac construct with decellularized small intestinal submucosa

Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds

Establishment of a heart-on-a-chip microdevice based on human iPS cells for the evaluation of human heart tissue function

A multi-cellular 3D bioprinting approach for vascularized heart tissue engineering based on HUVECs and iPSC-derived cardiomyocytes

Synergistic generation of cardiac resident-like macrophages and cardiomyocyte maturation in tissue engineered platforms